Delhi HC stays sales stoppage order on Pfizer’s Corex syrup
The Delhi High Court on Monday granted interim stay of notification restraining sale of pharma major Pfizer's cough syrup 'Corex' and directed the government not to take coercive steps against the company.
Justice Rajiv Sahai Endlaw granted the interim relief to the company saying it has been selling the cough syrup for the last 25 years. The court also issued notice to the Health ministry directing it to file status report after taking instruction on what was the finding of the expert committee set up by it following which sale of over 300 drugs' combination have been banned across India with effect from March 10.
"List on Monday. Till then the effect of notification qua the petitioner shall remain stayed. No coercive steps till then," the court said. The court's order came on a plea moved by Pfizer who contended that no show cause notice or hearing was granted prior to the notification. The Health Ministry, through a gazette notification, has banned over 300 fixed dose combination drugs, including cough syrups compositions, saying they involve "risk" to humans and safer alternatives were available.
Central government Standing Counsel Kirtiman Singh supported the notification, saying there are various complaints of misuse of drugs. The counsel said he will obtain instructions and file a short affidavit.
Pfizer has sought quashing of the government's March 10 notification contending they have been in market for 25 years and Corex is a prescription drug.